CYduct Diagnostics, Inc. engages in the development and marketing of technology, applications, medical devices, and procedural techniques for screening, diagnosis, treatment, and management of disease and medical conditions. The company is headquartered in Westport, Connecticut. The company went IPO on 2001-06-21. The firm focuses on the women's healthcare market, primarily breast healthcare and wellness. The company is focused on breast health and wellness through testing methods. The company focuses to provide a technology platform that includes evidence-based personalized breast health risk assessment testing. The firm serves medical schools, hospitals and physicians to develop medical devices and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions.
CYDX stock price ended at $0.4 on 星期四, after dropping 34.43%
On the latest trading day May 21, 2026, the stock price of CYDX fell by 34.43%, dropping from $0.40 to $0.40. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.40 and a high of $0.40. On the latest trading day, the trading volume for CYDX rose by 249 shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 250 shares were traded, with a market value of approximately $2.0M.